Oncolytic adenoviruses are a promising tool in cancer therapy. In this study, we characterized the role of autophagy in oncolytic adenovirus-induced therapeutic effects. OBP-405, an oncolytic adenovirus regulated by the human telomerase reverse transcriptase promoter (hTERT-Ad, OBP-301) with a tropism modification (RGD) exhibited a strong antitumor effect on glioblastoma cells. When autophagy was inhibited pharmacologically, the cytotoxicity of OBP-405 was attenuated. In addition, autophagy-deficient We have shown that the oncolytic adenovirus regulated by the human telomerase reverse transcriptase promoter (hTERT-Ad) induces nonapoptotic autophagy in glioblastoma cells.
Oncolytic adenoviruses have recently been developed as a novel cancer therapy. 1, 2 We have shown that the oncolytic adenovirus regulated by the human telomerase reverse transcriptase promoter (hTERT-Ad) induces nonapoptotic autophagy in glioblastoma cells. 3 However, the molecular machinery underlying autophagy-induced cell death remains unclear. [4] [5] [6] Furthermore, the processes determining whether autophagy in cancer cells causes death or acts as a protective mechanism activated during cellular distress are unknown. In this study, we elucidated the therapeutic role of autophagy in hTERT-Ad infection.
The infection efficiency of adenoviral constructs, which are derived from human adenovirus serotype 5, varies widely depending on the cellular expression of the coxsackievirus and adenovirus receptor (CAR). 7 Modification of the adenoviral fiber protein is one approach to overcoming the limitation imposed by this dependence on CAR. 8 A recent study demonstrated the activity of OBP-405, which is an hTERT-Ad with a tropism modification (RGD): OBP-405 had a profound oncolytic effect in vitro and in vivo on lung and colon cancer cells regardless of the CAR expression level. 9 In addition, for cells with low CAR expression levels, OBP-405 had a higher rate of infection than did OBP-301, an hTERT-Ad that expresses the E1A gene under the control of a 455-bp hTERT promoter. 9 The hTERT-Ad that we used previously has a 255-bp hTERT promoter. 3 Good manufacturing practice OBP-301 (Telomelysin) and OBP-405 (Telomelysin-RGD) were used in the current study. We first determined the expression levels of CAR and integrins (avb3 and avb5) on the cell surface of glioblastoma cells. To predict the response of human glioblastoma to OBP-301 or OBP-405, the established cell lines U87-MG, U251-MG, D54, and U373-MG and primary MDC-01 cells isolated from glioblastoma tissue were used. The U87-MG, D54 and MDC-01 cells expressed the lowest levels of CAR, whereas the U251-MG cells expressed the highest level of CAR (Figure 1a) . In contrast, avb3 and avb5 integrins were highly expressed in each of these glioblastoma cells. Cells that expressed low levels of CAR were resistant to OBP-301 infection, whereas OBP-405 effectively decreased viabi-lity of glioblastoma cells (Figure 1b) . In addition, OBP-405 killed the cells more efficiently than did OBP-301, and neither OBP-301 nor OBP-405 induced apoptosis (Figure 1c) (Supplementary Figures 1a-c) .
Nonapoptotic autophagy is characterized by the development of acidic vesicular organelles (AVOs). 10 Compared with mock infection, both OBP-301 and OBP-405 increased the percentage of AVO-positive cells in a multiplicity of infection (MOI)-dependent manner ( Figure 1d ). As expected, OBP-405 induced the development of AVOs more efficiently than did OBP-301. In acridine orange-stained cells, the cytoplasm and nucleus fluorescence bright green and dim red, whereas acidic compartments fluorescence bright red. 10, 11 The intensity of the red fluorescence is proportional to the degree of acidity and volume of AVOs. Top of grid was considered as AVOs. CAR, coxsackievirus and adenovirus receptor; IgG, immunoglobulin G; MOI, multiplicity of infection.
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The green fluorescent protein (GFP)-tagged expression vector of LC3 is a useful tool with which to detect autophagy. 12 On fluorescence microscopy, GFP-LC3-transfected U87-MG cells showed the diffuse distribution of GFP-LC3 with mock infection, whereas infection with OBP-405 at an MOI of 1.0 resulted in a punctate pattern of GFP-LC3 (Supplementary Figure 2a) . This pattern represents autophagic vacuoles and indicated that OBP-405 induced autophagy. With both OBP-301 and OBP-405, the percentage of GFP-LC3 dots increased in an MOI-dependent manner; this increase was considerably higher with OBP-405 than with OBP-301.
The LC3 protein exists in two cellular forms, LC3-I and LC3-II. LC3-I is converted to LC3-II by conjugation to phosphatidylethanolamine, and the amount of LC3-II is closely correlated with the number of autophagosomes. 13 In both U87-MG and U251-MG cells, the amount of LC3-II was increased by infection with OBP-301 or OBP-405 in an MOI-dependent manner and by OBP-405 in a time-dependent manner (Supplementary Figure 2b) . These results indicated that OBP-405 caused more autophagy in glioblastoma cells than OBP-301 did.
To analyze the association between adenoviral infection and autophagy, we determined the localization of OBP-405 and autophagic vacuoles. The adenoviral hexon was detected in the cytoplasm 6 h after infection, but at that point, autophagic vacuoles positive for the isoform B of human LC3 (LC3B) were not observed (Supplementary Figure 3 ), indicating that autophagy was not initiated. Twenty-four hours after infection, hexon was detected in the cytoplasm and nucleus and LC3B-positive autophagic vacuoles were observed. At 48 h, the cell and nucleus had become larger. At 72 h after infection, the majority of the autophagic vacuoles were colocalized with hexon-positive adenoviruses (Figure 2a ). In addition, we analyzed the ultrastructure of infected U87-MG cells. U87-MG cells infected with control nonreplicating adenovirus (Ad-LacZ) exhibited few autophagic features, whereas autophagic vacuoles, autolysosomes and empty vacuoles were observed after infection with OBP-405. Most OBP-405-infected cells ) antibodies. Anti-LC3B antibody was generated as described previously. 14, 15 The slides were monitored using inverted microscope (ECRIPSE TE2000-U; Nikon, Melville, NY, USA) and the data were deconvolved and analyzed using AutoQuant OBP-405-induced autophagy in malignant glioma T Yokoyama et al exhibited viral particles in the nucleus and cytoplasm, but they exhibited neither the chromatin condensation nor the DNA fragmentation that is the characteristic of apoptosis (Figure 2b) . Interestingly, viral particles were observed inside autophagic vacuoles. These results suggested that OBP-405 infection initiated the autophagic process and that the autophagic vacuoles sequestered replicating OBP-405.
To assess the role of autophagy in OBP-405 infection, we inhibited the OBP-405-induced autophagy pharmacologically by using 3-methyladenine (3-MA);
18 the decreased viability of these cells was significantly reversed (Po0.01) (Supplementary Figures 4a and b) . However, the inhibition of autophagy did not affect the increase in E1A copy number of OBP-405 (Supplementary Figure 4c ). To exclude the possibility that the effects of 3-MA are independent of inhibition of autophagy, we inhibited autophagy specifically by using small interfering RNA (siRNA) directed against autophagy-related gene 5 (Atg5), which is essential for autophagosome formation. Transfection with Atg5 siRNA effectively inhibited OBP-405-induced autophagy and recovered the OBP-405-inhibited viability of U87-MG and U251-MG cells (Supplementary Figure 5a-c) . Together, the results indicated that OBP-405 induced cell death through autophagy.
In addition, Atg5 À/À mouse embryonic fibroblasts (MEFs) were significantly more resistant to OBP-405-induced death than the wild-type MEFs (Po0.01) (Figures 3a and b) . This observation supported our results with 3-MA and Atg5 siRNA. Similar to 3-MA, viral replication of OBP-405 did not differ significantly between the wild-type and Atg5 À/À MEFs (Figure 3c ). The above observations prompted us to hypothesize that the antitumor effect of OBP-405 would be augmented by the combinatorial therapy with other autophagyinducing agents. To test our hypothesis, we combined OBP-405 with rapamycin, an inhibitor of the mammalian target of rapamycin and the DNA-alkylating agent temozolomide (TMZ), both of which efficiently induce autophagy. 19, 20 Rapamycin and TMZ not only enhanced OBP-405-induced autophagy in vitro but also synergized with OBP-405 to induce the death of glioblastoma cells (Figures 4a and b; Supplementary Figure 6 ). In contrast, TMZ or rapamycin did not alter viral replication ( Figure  4c ). Thus OBP-405 synergizes with autophagy-inducing agents to increase cell death in vitro.
To determine whether the in vitro effect of OBP-405 with TMZ or rapamycin translates to greater activity in vivo, we established intracranial tumors in nude mice. Compared with mice treated with Ad-LacZ, mice treated with OBP-405 lived significantly longer (mean survival ¼ 27.5 vs 34.0 days; difference (95% confidence interval) ¼ 6.0 (3.0-9.1) days; P ¼ 0.0008) (Figure 5a ). Mice treated with TMZ also survived significantly longer (mean survival ¼ 27.5 vs 37.0 days; difference ¼ 10 . The E1A DNA copy number was determined by quantitative realtime PCR, using a Power SYBR Green PCR Master Mix (Applied Biosystems, Foster, CA, USA) and 7500 real-time PCR systems (Applied Biosystems), as described previously. 9 The amount of viral E1A copy number is defined as the fold increase for each sample relative to that at 2 h. MEFs, mouse embryonic fibroblasts; MOI, multiplicity of infection
T Yokoyama et al , as described previously. 19 In the isobologram, a plot on the diagonal line indicates that the combination is simply additive. A plot to the left under the line indicates that the combination is synergistic, whereas a plot to the right above the line indicates that it is antagonistic. Each plot represents values generated in at least three independent experiments for the simultaneous treatment of cells. (b) Development of acidic vesicular organelles (AVOs) in U87-MG and U251-MG cells infected with OBP-405 at an MOI of 0.5 in the presence of 1 nM rapamycin (Sigma-Aldrich) or 100 mM TMZ were stained with 1.0 mg ml À1 acridine orange as described previously. 10, 11 Top of grid was considered as AVOs. (c) E1A viral replication of U87-MG and U251-MG cells infected with OBP-405 at an MOI of 0.5 alone or with 1 nM rapamycin or 100 mM TMZ over 72 h as described previously. 9 MOI, multiplicity of infection; TMZ, temozolomide.
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The intracranial tumors of mice treated with Ad-LacZ, OBP-405, TMZ or RAD001 alone grew extensively, with midlines shifted laterally. Strikingly, tumors were undetectable in brain tissue harvested from three mice treated with OBP-405 plus TMZ that survived 60 days after inoculation (Figure 5b ). Hexon was detected in the intracranial tumor treated with OBP-405 plus TMZ (day 45) but not in the tumor treated with Ad-LacZ (day 28) (Supplementary Figure 7) . This finding was supported by western blotting results showing detectable E1A protein expression in intracranial tumors treated with OBP-405 alone or with TMZ ( Figure 5c ). These results indicated that OBP-405 replicated and spread through the intracranial tumors but not through the normal brain tissues and supported the contention that the effect of OBP-405 is specific to tumors, likely due to the hTERT promoter activity. Then, we determined whether the induction of autophagy is detected under in vivo settings using an anti-LC3B-specific antibody. As shown in Figure 5c , the amount of LC3-II was higher in intracranial tumors of mice treated with TMZ, OBP-405 and OBP-405 plus TMZ than in Ad-LacZ-treated mice. These results indicated that autophagy was induced in intracranial tumors of mice as well as in vitro and that the extent of autophagy was enhanced by the combination treatment. However, intracranial tumors established from noninvasive glioblastoma cell lines may limit the clinical relevance of studies assessing the efficacy of novel therapies. 21 Therefore, we will further assess whether the treatment with OBP-405 plus TMZ or RAD001 prolong the survival of the mice carrying invasive intracranial tumors. 21 In conclusion, we found that the fiber-modified hTERT-Ad OBP-405 has a marked antitumor effect on glioblastoma cells regardless of the cellular expression level of CAR. Moreover, autophagy-inducing agents (TMZ and rapamycin) increase the in vitro and in vivo antitumor activity of OBP-405 through the enhancement of autophagic pathway. A recent clinical study showed that TMZ had antitumor activity both as a single agent ) was established as described previously. 3 Three days after the inoculation of U87-MG cells (day 0), the treatments were initiated as follows. On days 3, 5 and 7, through a 10 ml Hamilton syringe fitted with a 26-gauge needle connected to a microinfusion pump, Ad-LacZ (2.2 Â 10 9 pfu ml À1 ) or OBP-405 (2.2 Â 10 9 pfu ml À1 ) in 10 ml of sterile PBS was infused into the tumors through the screw guide at a depth of 3.5 mm from the skull. Two hundred microliters of TMZ (7.5 mg kg À1 in PBS with 5% dimethyl sulfoxide) was injected intraperitoneally five times a week for 2 weeks, and RAD001 (5 mg kg À1 in water, kindly supplied by Norvartis, Basel, Switzerland) was administered orally every day until the animals became moribund and were killed. 
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